We are adding United Natural Foods Inc. (UNFI) to the Hedgeye Consumer Staples LONG bench. We intend to do a deep dive into this company over the next month, to get to the bottom of where we stand on it.




This stock has been beaten down way too far, due to an overreaction from the fallout of one big customer, Albertsons. The stock is down 42% from its 52-week high and down 24% over the last year.




Given the strong guidance for 4Q15 and the upbeat guidance heading into FY16 we are confident in the ability of this company to succeed. The thought that UNFI will continue to lose customers from competition is overblown and not very realistic in our minds. UNFI provides a high level service, offering a wide variety of over 80,000 products at industry leading prices. The industry is seeing continued growth in natural & organic, specialty, ethnic gourmet and fresh, all of which UNFI offers and can package together to provide retailers great value. Management is hinting towards positive results in the first two weeks of FY16, although only two weeks, it’s nice to hear of a marked sequential improvement.


UNFI has gone through a period of investment in capacity over the last couple of year. They are now past this, therefore capex with be falling down to more modest levels, about 0.6% - 0.7% of net sales. Free cash flow is going to start to ramp up as they invest less and leverage their assets more; this will lead to the possibility of doing bigger acquisitions.


Their main competitor, KeHe, recently was selected as UNFI’s replacement as the primary natural & organic distributor to serve Albertsons. It is our belief that KeHe is going to be busy integrating this business, therefore unable to go after any large contracts in the near future.



On August 19, 2015, UNFI released preliminary 4Q15 and FY15 results as well as FY16 guidance (September 14th is the formal announce date). The company anticipates net sales in the range of $2.060 billion to $2.065 billion, versus consensus estimates of $2.051 billion. UNFI's diluted EPS for the fourth quarter of 2015 will be in the range of $0.72 to $0.73, which will match or exceed consensus estimates of $0.72.


Management also provided their FY16 outlook; the company expects net sales in the range of $8.51 billion to $8.67 billion, which represents an increase of 4% to 6% over FY15. Currently, consensus estimates for FY16 net sales are $8.596, so management is hinting at something slightly above that.


From listening to the pre-announcement conference call we get the feeling that they are leaving some in their pocket for a rainy day.  There is a strong possibility of gaining new customers in the coming year, as well as acquiring a business or two as they hinted at in the call.



In early research, taking a conservative approach to multiple and EBITDA growth we are getting to a bull case of about $70/share or ~46% upside from here.




A lot more research to go through, but we are confident that the stock has bottomed, and has all negativity built in.


We will share pivotal information with you as we dig in here. Please call or e-mail with any questions.


Howard Penney

Managing Director


Shayne Laidlaw





Cartoon of the Day: Crash Test Bear

In the past six months, U.S. stock indices are up between +12% and +18%.

read more

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more